Stock Research for NWBO


Featured Broker: Ally Invest

Get the due diligence for another stock.


NWBO Stock Chart & Research Data

The NWBO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NWBO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


NWBO Due diligence Resources & Stock Charts

The NWBO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NWBO Detailed Price Forecast - CNN Money CNN View NWBO Detailed Summary - Google Finance
Yahoo View NWBO Detailed Summary - Yahoo! Finance Zacks View NWBO Stock Research & Analysis -

Stock Analysis

TradeIdeas View NWBO Trends & Analysis - Trade-Ideas Barrons View NWBO Major Holders - Barrons
NASDAQ View NWBO Call Transcripts - NASDAQ Seeking View NWBO Breaking News & Analysis - Seeking Alpha
Spotlight View NWBO Annual Report - OTC Report View NWBO OTC Short Report -
TradeKing View NWBO Fundamentals - TradeKing Charts View NWBO SEC Filings - Bar Chart
WSJ View Historical Prices for NWBO - The WSJ Morningstar View Performance/Total Return for NWBO - Morningstar
MarketWatch View the Analyst Estimates for NWBO - MarketWatch CNBC View the Earnings History for NWBO - CNBC
StockMarketWatch View the NWBO Earnings - StockMarketWatch MacroAxis View NWBO Buy or Sell Recommendations - MacroAxis
Bullish View the NWBO Bullish Patterns - American Bulls Short Pains View NWBO Short Pain Metrics -

Social Media Mentions

StockTwits View NWBO Stock Mentions - StockTwits PennyStocks View NWBO Stock Mentions - PennyStockTweets
Twitter View NWBO Stock Mentions - Twitter Invest Hub View NWBO Investment Forum News - Investor Hub
Yahoo View NWBO Stock Mentions - Yahoo! Message Board Seeking Alpha View NWBO Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for NWBO - Insider Cow View Insider Transactions for NWBO - Insider Cow
CNBC View NWBO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NWBO - OTC Markets
Yahoo View Insider Transactions for NWBO - Yahoo! Finance NASDAQ View Institutional Holdings for NWBO - NASDAQ

Stock Charts

FinViz View NWBO Stock Insight & Charts - StockCharts View NWBO Investment Charts -
BarChart View NWBO Stock Overview & Charts - BarChart Trading View View NWBO User Generated Charts - Trading View

Latest Financial News for NWBO

NW Bio Announces That UK Property Transaction Has Closed, Including Funding of Approximately $47.3 Million Gross Proceeds
Posted on Friday December 14, 2018

BETHESDA, Md. , Dec. 14, 2018 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) -- ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, ...

NW Bio Announces Non-Dilutive Funding of Approximately $47.3 Million Through UK Property Transaction
Posted on Tuesday December 11, 2018

The Company will sell most of its UK property to the multi-national corporation. The Company will receive £37.5 million (approximately $47.3 million) cash payment at closing. The Company will retain ownership of 17 acres of the property, which are excluded from the sale and which the Company believes will have substantial additional value in the future.

Growth Opportunities in Stocks Coming Off of Bottoms
Posted on Tuesday November 27, 2018

HENDERSON, NV / ACCESSWIRE / November 27, 2018 / With the market in a bit of a swoon, many companies with positive 3 rd quarter announcements have not yet seen them baked into the share price properly. ...

Northwest Biotherapeutics Releases Phase III Data for DCVax(R)-L and Secures New Financing
Posted on Monday November 26, 2018

DCVax®-L for Glioblastoma is the company's lead product for the treatment of newly diagnosed Glioblastoma. The company stock has moved from $.214 to $.29 in recent days as the company released data from its DCVax®-L phase III study.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.